New Zealand's PHARMAC Gains $41 Million In Funding; Adds Sprycel And Humira For Reimbursement
This article was originally published in PharmAsia News
PERTH, Australia - New Zealand's Pharmaceutical Management Agency's 2009/2010 budget saw a $41 million increase, bringing the total agency budget to $694 million, with $10 million of the new funds transferred from New Zealand District Health Board budgets
You may also be interested in...
The pharmaceutical industry should prepare for an expansion of the 340B drug discount program in the U.S. - regardless of the outcome of the health care reform debate
The drug maker also reports rising sales for its dyslipidemia franchise.
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).